Creative Medical Technology Holdings Announces Creation of Amniotic Fluid Stem Cell Focused Subsidiary … – PR Newswire (press release)
|
Creative Medical Technology Holdings Announces Creation of Amniotic Fluid Stem Cell Focused Subsidiary …
PR Newswire (press release) 16, 2016 /PRNewswire/ — Creative Medical Technology Holdings (OTCQB:CELZ) announced today the formation of a wholly-owned subsidiary, AmnioStem LLC, focused on the development of therapeutic products derived from amniotic fluid stem cells. |
